Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial.
Fiche publication
Date publication
décembre 2020
Journal
Translational oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr EBERST Lauriane
Tous les auteurs :
Arnaud-Coffin P, Brahmi M, Vanacker H, Eberst L, Tredan O, Attignon V, Pissaloux D, Sohier E, Cassier P, Garin G, Pérol D, Blay JY, Dufresne A
Lien Pubmed
Résumé
Advanced sarcoma is a group of heterogeneous disease with poor prognosis and poor efficacy of medical treatment. They represent a promising group of tumors to assess molecular-based therapy (MBT) strategy.
Mots clés
Advanced cancer, Molecular profiling, Molecular-targeted therapy, Precision medicine, Sarcoma
Référence
Transl Oncol. 2020 Dec;13(12):100870